Skip to content

Effect ofAI Agent-Based Inhaler Use Assessment Tool

Development and Application of an AI Agent-Based Inhaler Use Assessment Tool: non-Randomized Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0011622
Enrollment
60
Registered
2026-02-19
Start date
2026-02-02
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others(AI-based inhaler education) : - For the intervention group, a trained interventionist reviews the AI agent–based inhaler use assessment results and provides individualized, one-on-one structure

Sponsors

Chonnam National University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - Adults aged 40 years or older who have been diagnosed with chronic obstructive pulmonary disease (COPD) or asthma as the primary diagnosis by a physician and are currently using inhalers. - Individuals with preserved cognitive and mental function who are able to understand the study procedures and comply with study instructions.

Exclusion criteria

Exclusion criteria: - Patients with neurological disorders or impaired motor function that may interfere with proper inhaler use. - Patients who have participated in an inhaler use assessment study within the past year. - Individuals who do not provide voluntary written informed consent to participate in the study.

Design outcomes

Primary

MeasureTime frame
inhaler technique

Secondary

MeasureTime frame
health-related quality of life score;self-efficacy for managing chronic disease score;inhaler adherence score;symptom control score

Countries

Korea, Republic of

Contacts

Public ContactSehyun Cho

Chonnam National University

sehyunstar@naver.com+82-62-530-4943

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Mar 14, 2026